HENRY SCHEIN INC (HSIC) Stock Fundamental Analysis

NASDAQ:HSIC • US8064071025

79.57 USD
+2.77 (+3.61%)
At close: Feb 20, 2026
80.1 USD
+0.53 (+0.67%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, HSIC scores 4 out of 10 in our fundamental rating. HSIC was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HSIC while its profitability can be described as average. HSIC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • HSIC had positive earnings in the past year.
  • In the past year HSIC had a positive cash flow from operations.
  • Each year in the past 5 years HSIC has been profitable.
  • In the past 5 years HSIC always reported a positive cash flow from operatings.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • HSIC has a Return On Assets of 3.52%. This is in the better half of the industry: HSIC outperforms 66.67% of its industry peers.
  • HSIC has a Return On Equity of 11.63%. This is in the better half of the industry: HSIC outperforms 75.49% of its industry peers.
  • HSIC has a better Return On Invested Capital (6.64%) than 64.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HSIC is in line with the industry average of 9.00%.
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROIC 6.64%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of HSIC (3.02%) is better than 67.65% of its industry peers.
  • In the last couple of years the Profit Margin of HSIC has declined.
  • Looking at the Operating Margin, with a value of 5.94%, HSIC is in the better half of the industry, outperforming 65.69% of the companies in the same industry.
  • HSIC's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 31.19%, HSIC is in line with its industry, outperforming 59.80% of the companies in the same industry.
  • HSIC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HSIC is destroying value.
  • The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
  • The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
  • HSIC has a worse debt/assets ratio than last year.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.66, HSIC is in line with its industry, outperforming 59.80% of the companies in the same industry.
  • HSIC has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as HSIC would need 8.70 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 8.70, HSIC perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
  • HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.91, HSIC is in line with its industry, outperforming 42.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Altman-Z 2.66
ROIC/WACC0.8
WACC8.25%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
  • HSIC has a Current ratio of 1.40. This is comparable to the rest of the industry: HSIC outperforms 51.96% of its industry peers.
  • A Quick Ratio of 0.79 indicates that HSIC may have some problems paying its short term obligations.
  • HSIC has a worse Quick ratio (0.79) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.79
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.49%, which is quite good.
  • HSIC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.19% yearly.
  • HSIC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.51%.
  • HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.88% yearly.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.78% on average over the next years.
  • HSIC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.31% yearly.
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y7.78%
Revenue Next Year2.46%
Revenue Next 2Y2.94%
Revenue Next 3Y3.22%
Revenue Next 5Y3.31%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.51, HSIC is valued correctly.
  • HSIC's Price/Earnings ratio is rather cheap when compared to the industry. HSIC is cheaper than 80.39% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (26.99), we can say HSIC is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 14.72 indicates a correct valuation of HSIC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 81.37% of the companies listed in the same industry.
  • HSIC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 16.51
Fwd PE 14.72
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HSIC is valued a bit cheaper than 72.55% of the companies in the same industry.
  • HSIC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.31
EV/EBITDA 10.32
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.83
PEG (5Y)2.67
EPS Next 2Y6.79%
EPS Next 3Y7.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HSIC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HENRY SCHEIN INC

NASDAQ:HSIC (2/20/2026, 8:00:01 PM)

After market: 80.1 +0.53 (+0.67%)

79.57

+2.77 (+3.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners97.45%
Inst Owner Change-0.99%
Ins Owners0.79%
Ins Owner Change-0.21%
Market Cap9.37B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts72.17
Price Target79.3 (-0.34%)
Short Float %5.13%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)5.91%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)0.33%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 14.72
P/S 0.72
P/FCF 26.31
P/OCF 17.51
P/B 2.79
P/tB N/A
EV/EBITDA 10.32
EPS(TTM)4.82
EY6.06%
EPS(NY)5.41
Fwd EY6.79%
FCF(TTM)3.02
FCFY3.8%
OCF(TTM)4.54
OCFY5.71%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.83
PEG (5Y)2.67
Graham Number55.64
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROCE 9.68%
ROIC 6.64%
ROICexc 6.74%
ROICexgc 16.65%
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
FCFM 2.75%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Debt/EBITDA 2.85
Cap/Depr 58.69%
Cap/Sales 1.38%
Interest Coverage 5.16
Cash Conversion 49.81%
Profit Quality 91.05%
Current Ratio 1.4
Quick Ratio 0.79
Altman-Z 2.66
F-Score5
WACC8.25%
ROIC/WACC0.8
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y7.78%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.46%
Revenue Next 2Y2.94%
Revenue Next 3Y3.22%
Revenue Next 5Y3.31%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.59%
EBIT Next 3Y8.39%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%

HENRY SCHEIN INC / HSIC FAQ

What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HSIC.


What is the valuation status of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.


Can you provide the profitability details for HENRY SCHEIN INC?

HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?

The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 16.51 and the Price/Book (PB) ratio is 2.79.


What is the earnings growth outlook for HENRY SCHEIN INC?

The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.82% in the next year.